These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26829391)

  • 1. Associations between Cognition, Gender and Monocyte Activation among HIV Infected Individuals in Nigeria.
    Royal W; Cherner M; Burdo TH; Umlauf A; Letendre SL; Jumare J; Abimiku A; Alabi P; Alkali N; Bwala S; Okwuasaba K; Eyzaguirre LM; Akolo C; Guo M; Williams KC; Blattner WA
    PLoS One; 2016; 11(2):e0147182. PubMed ID: 26829391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria.
    Akolo C; Royal W; Cherner M; Okwuasaba K; Eyzaguirre L; Adebiyi R; Umlauf A; Hendrix T; Johnson J; Abimiku A; Blattner WA
    J Neurovirol; 2014 Aug; 20(4):380-7. PubMed ID: 24927825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte Activation Is Associated With Worse Cognitive Performance in HIV-Infected Women With Virologic Suppression.
    Imp BM; Rubin LH; Tien PC; Plankey MW; Golub ET; French AL; Valcour VG
    J Infect Dis; 2017 Jan; 215(1):114-121. PubMed ID: 27789726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria.
    Royal W; Cherner M; Carr J; Habib AG; Akomolafe A; Abimiku A; Charurat M; Farley J; Oluyemisi A; Mamadu I; Johnson J; Ellis R; McCutchan JA; Grant I; Blattner WA
    J Neurovirol; 2012 Jun; 18(3):191-9. PubMed ID: 22528480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection.
    Burdo TH; Weiffenbach A; Woods SP; Letendre S; Ellis RJ; Williams KC
    AIDS; 2013 Jun; 27(9):1387-95. PubMed ID: 23435298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral biomarkers do not correlate with cognitive impairment in highly active antiretroviral therapy-treated subjects with human immunodeficiency virus type 1 infection.
    Sun B; Abadjian L; Rempel H; Calosing C; Rothlind J; Pulliam L
    J Neurovirol; 2010 Mar; 16(2):115-24. PubMed ID: 20307252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Cognitive Performance and Reduced Monocyte Activation in Virally Suppressed Chronic HIV After Dual CCR2 and CCR5 Antagonism.
    DʼAntoni ML; Paul RH; Mitchell BI; Kohorn L; Fischer L; Lefebvre E; Seyedkazemi S; Nakamoto BK; Walker M; Kallianpur KJ; Ogata-Arakaki D; Ndhlovu LC; Shikuma C
    J Acquir Immune Defic Syndr; 2018 Sep; 79(1):108-116. PubMed ID: 29781885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Plasma Levels of sCD14 and MCP-1 Are Associated With HIV Associated Neurocognitive Disorders Among Antiretroviral-Naive Individuals in Nigeria.
    Jumare J; Akolo C; Ndembi N; Bwala S; Alabi P; Okwuasaba K; Adebiyi R; Umlauf A; Cherner M; Abimiku A; Charurat M; Blattner WA; Royal W
    J Acquir Immune Defic Syndr; 2020 Jun; 84(2):196-202. PubMed ID: 32084055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection.
    Kamat A; Lyons JL; Misra V; Uno H; Morgello S; Singer EJ; Gabuzda D
    J Acquir Immune Defic Syndr; 2012 Jul; 60(3):234-43. PubMed ID: 22569268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased monocyte activation with age among HIV-infected long term non-progressor children: implications for early treatment initiation.
    D'Souza RR; Gopalan BP; Rajnala N; Phetsouphanh C; Shet A
    HIV Med; 2019 Sep; 20(8):513-522. PubMed ID: 31131542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological performance in HIV-1-infected homosexual men: The Multicenter AIDS Cohort Study (MACS).
    Miller EN; Selnes OA; McArthur JC; Satz P; Becker JT; Cohen BA; Sheridan K; Machado AM; Van Gorp WG; Visscher B
    Neurology; 1990 Feb; 40(2):197-203. PubMed ID: 2405289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: a changing paradigm for routine HIV laboratory monitoring?
    Castley A; Berry C; French M; Fernandez S; Krueger R; Nolan D
    PLoS One; 2014; 9(12):e115226. PubMed ID: 25544986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymptomatic Malaria Co-infection of HIV-Infected Adults in Nigeria: Prevalence of and Impact on Cognition, Mood, and Biomarkers of Systemic Inflammation.
    Bharti AR; McCutchan JA; Umlauf A; Okwuegbuna OK; Letendre S; Cherner M; Burdo T; Jumare J; Williams K; Blattner W; Royal W
    J Acquir Immune Defic Syndr; 2021 Jan; 86(1):91-97. PubMed ID: 33021552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection.
    Lyons JL; Uno H; Ancuta P; Kamat A; Moore DJ; Singer EJ; Morgello S; Gabuzda D
    J Acquir Immune Defic Syndr; 2011 Aug; 57(5):371-9. PubMed ID: 21646912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CD163 and monocyte populations in response to antiretroviral therapy and in relationship with neuropsychological testing among HIV-infected children.
    Ananworanich J; Kerr SJ; Jaimulwong T; Vibol U; Hansudewechakul R; Kosalaraksa P; Ngampiyaskul C; Kanjanavanit S; Wongsawat J; Luesomboon W; Apornpong T; Soulas C; Paul R; Ruxrungtham K; Puthanakit T
    J Virus Erad; 2015; 1(3):196-202. PubMed ID: 26835517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Reduction in Monocyte Activation and Vascular Inflammation With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among HIV-Infected Individuals.
    Hileman CO; Kinley B; Scharen-Guivel V; Melbourne K; Szwarcberg J; Robinson J; Lederman MM; Mccomsey GA
    J Infect Dis; 2015 Aug; 212(3):345-54. PubMed ID: 25583168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Activation Is Associated With Neurocognitive Performance in Ugandan Adolescents Living With HIV.
    Dirajlal-Fargo S; Sattar A; Strah M; Karungi C; Gumikiriza-Onoria JL; Santoro AF; Kirsch C; Nanteza A; Ferraris CM; Tsapalas D; Asiedu N; Funderburg N; Musiime V; McComsey GA; Robbins RN
    J Acquir Immune Defic Syndr; 2024 Nov; 97(3):296-304. PubMed ID: 38902861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of cigarette smoking with viral immune and cognitive function in human immunodeficiency virus-seropositive women.
    Wojna V; Robles L; Skolasky RL; Mayo R; Selnes O; de la Torre T; Maldonado E; Nath A; Meléndez LM; Lasalde-Dominicci J
    J Neurovirol; 2007 Dec; 13(6):561-8. PubMed ID: 18097887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Select neurocognitive impairment in HIV-infected women: associations with HIV viral load, hepatitis C virus, and depression, but not leukocyte telomere length.
    Giesbrecht CJ; Thornton AE; Hall-Patch C; Maan EJ; Côté HC; Money DM; Murray M; Pick N
    PLoS One; 2014; 9(3):e89556. PubMed ID: 24595021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma HIV RNA level is associated with neurocognitive function among HIV-1-infected patients in Nigeria.
    Jumare J; El-Kamary SS; Magder L; Hungerford L; Ndembi N; Aliyu A; Dakum P; Umlauf A; Cherner M; Abimiku A; Charurat M; Blattner WA; Royal W
    J Neurovirol; 2018 Dec; 24(6):712-719. PubMed ID: 30168015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.